A New Nuclear Rival Recently Filed to Go Public. Should Oklo Investors Be Worried?

Holtec Nuclear filed for an IPO on Nasdaq, presenting a lower-risk alternative to Oklo in the nuclear sector. Unlike Oklo, Holtec is an established company with $165 million in quarterly revenue and $17.8 million in net income, while Oklo remains pre-commercial with only $1.2 million in quarterly revenue and significant losses. Holtec's existing nuclear fuel management business funds its SMR development, whereas Oklo faces continued cash burn until reaching commercial operations around 2028.